Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endobronchial metastases.

R H Fitzgerald

    Southern Medical Journal
    |April 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Endobronchial metastases from breast cancer can be treated with resection, radiation, or systemic therapy. Patients with longer disease-free intervals after bronchial metastases diagnosis showed improved survival rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Post-discharge prevention of deep vein thrombosis following total joint replacement.

    Orthopedics·2014
    Same author

    Managing the risk of venous thromboembolism in orthopedics: introductory remarks.

    Orthopedics·2014
    Same author

    Preventing dvt following total knee replacement: a review of recent clinical trials.

    Orthopedics·2014
    Same author

    Secondary osteomyelitis.

    Canadian Medical Association journal·2010
    Same author

    Laundering protocols for chlorpyrifos residue removal from pest control operators' overalls.

    Bulletin of environmental contamination and toxicology·2005
    Same author

    Contribution of acetabular labrum to articulating surface area and femoral head coverage in adult hip joints: an anatomic study in cadavera.

    American journal of orthopedics (Belle Mead, N.J.)·2002
    Same journal

    The Five Essential Concepts of Developmental Medicine: A Medical Paradigm for People with Developmental Disabilities.

    Southern medical journal·2026
    Same journal

    α-Gal Syndrome in the South: Why We Need Treatment Trials, Not Just Tick Prevention.

    Southern medical journal·2026
    Same journal

    Association between Main Pancreatic Duct Size, Comorbidities, and Fistula Formation after Whipple Procedure for Pancreatic Cancer.

    Southern medical journal·2026
    Same journal

    Impact of Temperature Variation on Patients with Acute Severe Asthma.

    Southern medical journal·2026
    Same journal

    Assessing the Accuracy and Reliability of ChatGPT-4 to Answer Clinical EHR Messages in Sports Medicine.

    Southern medical journal·2026
    Same journal

    Diagnostic Utility and Clinical Implications of Inpatient Fecal Occult Blood Testing.

    Southern medical journal·2026
    See all related articles

    Area of Science:

    • Pulmonology
    • Oncology

    Background:

    • Endobronchial metastases are rare but significant pulmonary complications.
    • Breast cancer is a common primary source of such metastases.

    Purpose of the Study:

    • To review cases of endobronchial metastases.
    • To analyze treatment outcomes and survival in relation to primary cancer type and disease-free interval.

    Main Methods:

    • Retrospective review of seventeen cases with endobronchial metastases.
    • Analysis of treatment modalities including resection, radiation, and systemic therapy.
    • Correlation of survival with primary tumor characteristics and disease-free intervals.

    Main Results:

    • Six of seventeen cases originated from breast cancer.

    Related Experiment Videos

  • Treatment varied, including surgical resection, radiation, and systemic therapies.
  • Longer survival was observed in breast cancer patients with extended disease-free intervals prior to bronchial metastasis.

    • Conclusions:

    • Endobronchial metastases from breast cancer require tailored treatment strategies.
    • Disease-free interval is a critical prognostic factor for survival in these patients.
    • Aggressive tumor types correlate with poorer outcomes.